1. de Vrese M, Marteau PR. Probiotics and prebiotics: effects on diarrhea. J Nutr 2007;137:803S-811S.PMID:
17311979.
2. Eizaguirre I, Urkia NG, Asensio AB, et al. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J Pediatr Surg 2002;37:699-702.PMID:
11987081.
3. Billoo AG, Memon MA, Khaskheli SA, et al. Role of a probiotic (
Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol 2006;12:4557-4560.PMID:
16874872.
4. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006;101:1581-1590.PMID:
16863564.
5. Oberhelman RA, Gilman RH, Sheen P, et al. A placebo-controlled trial of
Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999;134:15-20.PMID:
9880443.
6. Dendukuri N, Costa V, McGregor M, Brophy JM. Probiotic therapy for the prevention and treatment of
Clostridium difficile-associated diarrhea: a systematic review. CMAJ 2005;173:167-170.PMID:
16027434.
7. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007;5:97-105.PMID:
17298915.
8. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000;130:396S-402S.PMID:
10721914.
9. Gaon D, Garcia H, Winter L, et al. Effect of
Lactobacillus strains and
Saccharomyces boulardii on persistent diarrhea in children. Medicina (B Aires) 2003;63:293-298.PMID:
14518142.
10. Bleichner G, Blehaut H, Mentec H, Moyse D.
Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 1997;23:517-523.PMID:
9201523.
11. Htwe K, Yee KS, Tin M, Vandenplas Y. Effect of
Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: a randomized controlled study. Am J Trop Med Hyg 2008;78:214-216.PMID:
18256417.
12. Fuller R. Probiotics in human medicine. Gut 1991;32:439-442.PMID:
1902810.
13. Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 1987;70:1-12.PMID:
3106442.
14. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of
Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;37:121-128.PMID:
1728516.
15. Castagliuolo I, LaMont JT, Nikulasson ST, Pothoulakis C.
Saccharomyces boulardii protease inhibits
Clostridium difficile toxin A effects in the rat ileum. Infect Immun 1996;64:5225-5232.PMID:
8945570.
16. Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C.
Saccharomyces boulardii protease inhibits the effects of
Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 1999;67:302-307.PMID:
9864230.
17. Pothoulakis C, Kelly CP, Joshi MA, et al.
Saccharomyces boulardii inhibits
Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993;104:1108-1115.PMID:
8462799.
18. Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998;42:39-44.PMID:
9706796.
19. Malin M, Suomalainen H, Saxelin M, Isolauri E. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with
Lactobacillus GG. Ann Nutr Metab 1996;40:137-145.PMID:
8862696.
20. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human
Lactobacillus strain. Pediatr Res 1992;32:141-144.PMID:
1324462.
21. de Boer AS, Priest F, Diderichsen B. On the industrial use of
Bacillus licheniformis: a review. Appl Microbiol Biotechnol 1994;40:595-598.
22. Rowland I. Probiotics and benefits to human health--the evidence in favour. Environ Microbiol 1999;1:375-376.PMID:
11207755.
23. Kim JY, Bae EA, Han MJ, Kim DH. Inhibitory activity of Bacillus licheniformis AJ on the growth of diarrheal pathogens. Biomol Ther 1999;7:385-389.
24. Kim Y, Cho JY, Kuk JH, et al. Identification and antimicrobial activity of phenylacetic acid produced by
Bacillus licheniformis isolated from fermented soybean, Chungkook-Jang. Curr Microbiol 2004;48:312-317.PMID:
15057459.
25. Nijland R, Hall MJ, Burgess JG. Dispersal of biofilms by secreted, matrix degrading, bacterial DNase. PLoS One 2010;5:e15668PMID:
21179489.
26. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of
Clostridium difficile disease. Am J Gastroenterol 2006;101:812-822.PMID:
16635227.
27. Ki Cha B, Mun Jung S, Hwan Choi C, et al. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Clin Gastroenterol 2012;46:220-227.PMID:
22157240.
28. Zhong YQ, Zhu J, Guo JN, et al. A randomized and case-control clinical study on trimebutine maleate in treating functional dyspepsia coexisting with diarrhea-dominant irritable bowel syndrome. Zhonghua Nei Ke Za Zhi 2007;46:899-902.PMID:
18261269.
29. O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000;32:294-301.PMID:
11515626.
30. Kim YG, Moon JT, Lee KM, Chon NR, Park H. The effects of probiotics on symptoms of irritable bowel syndrome. Korean J Gastroenterol 2006;47:413-419.PMID:
16809947.